Original language | English |
---|---|
Journal | JMIR Research Protocols |
Publication status | Published - 18 Sep 2017 |
Clinical Methods and Design for a Phase II Randomised Control Trial to Assess the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in Idiopathic Intracranial Hypertension: IIH:DT.
Keira Markey, Ryan Ottridge, James Mitchell, Caroline Rick, Rebecca Woolley, Natalie Ives, P Nightingale, Alex Sinclair
Research output: Contribution to journal › Article › peer-review